1st Quarter - Termination

BRYAN CAVE LEIGHTON PAISNER LLP for HORIZON PHARMA, INC.

Firm
Client
Income
$30,000
Expenses
—
Terminated
Jan 31, 2016

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2016 $10,000 Replaced
1st Quarter - Termination (this page) Jul 7, 2016 $30,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Innovation Act HR 9

Foreign entity interest: Horizon Pharma PLC, the entity listed on the LD-1, is the parent company.

LobbyistCovered position, as disclosed
WILLIAM APPLEGATE —
MATT JESSEE —
DAVID RUSSELL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.